Abbreviated Gadoxetic Acid-enhanced MRI with Second-Shot Arterial Phase Imaging for Liver Metastasis Evaluation.

PURPOSE

To evaluate the feasibility of an abbreviated gadoxetic acid-enhanced MRI protocol including second-shot arterial phase (SSAP) imaging for liver metastasis evaluation.

MATERIALS AND METHODS

For this retrospective study, a total of 197 patients with cancer (117 men and 80 women; mean age, 62.9 years) were included who underwent gadoxetic acid-enhanced MRI performed by using a modified injection protocol for liver metastasis evaluation from July to August 2017. The modified injection protocol included routine dynamic imaging after a first injection of 6 mL and SSAP imaging after a second injection of 4 mL. Image set 1 was obtained with the full original protocol. Image set 2 consisted of T2-weighted, diffusion-weighted, hepatobiliary phase, and SSAP images (the simulated abbreviated protocol). Acquisition time was measured in each image set. The diagnostic performance of each image set was compared by using a jackknife alternative free-response receiver operating characteristic analysis. Image quality evaluation and visual assessment of vascularity were performed on the original arterial phase images, the SSAP images, and their subtraction images.

RESULTS

The acquisition time was significantly shorter in image set 2 than in image set 1 (18.6 vs 6.2 minutes, <.0001). The reader-averaged figure-of-merit was not significantly different between image sets 1 and 2 ( = .197). The mean motion artifact score was significantly lower for the SSAP images than for the original arterial phase images ( <.001). All hypervascular metastases ( = 72) showed hyperintensity on the SSAP and/or the second subtraction images.

CONCLUSION

An abbreviated MRI protocol including SSAP is feasible for liver metastasis evaluation, providing faster image acquisition while preserving diagnostic performance, image quality, and visual vascularity. Abdomen/GI, Comparative Studies, Liver, MR-Imaging, Metastases© RSNA, 2019